Recruiting Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study NCT06016387 Conditions Breast Diseases, Breast Neoplasms, Central Nervous System Neoplasms, +9 more Locations The Ottawa Hospital — Ottawa, Ontario, Canada Sunnybrook Health Sciences Centre — Toronto, Ontario, Canada View Trial Details
Active, Not Recruiting Study Assessing QBS72S For Treating Brain Metastases NCT05305365 Conditions Brain Diseases, Brain Metastases, Brain Neoplasms, +20 more Locations Stanford Cancer Institute — Palo Alto, California, United States View Trial Details
